Mock — Lab Reports Promising Results in Malaria Vaccine Trial
Phase two data showed durable immune responses across adolescent cohorts in three countries.
Researchers stressed that regulatory review will take time and that manufacturing partnerships are still under negotiation.
Public health teams welcomed the signal but cautioned against comparing efficacy numbers with earlier-generation tools without matching study conditions.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (2)